InvestLog
AMLX logo

AMLX

Amylyx Pharmaceuticals, Inc.NASDAQHealthcare
$14.95+4.18%ClosedMarket Cap: $1.24B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-25HC Wainwright & Co.—Buy—
2026-03-19Guggenheim—Buy—
2026-02-20B of A Securities—Buy—
2026-02-10HC Wainwright & Co.—Buy—
2025-11-07HC Wainwright & Co.—Buy—
2025-10-17Citigroup—Buy—
2025-10-16Baird—Outperform—
2025-10-03B of A Securities—Buy—
2025-09-16Goldman Sachs—Buy—
2025-09-15Guggenheim—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-1.24$44.7M7
Sun Dec 31$-0.57$153.2M6
Mon Dec 31$0.69$321.4M4
Tue Dec 31$2.07$538.3M2